GL1X · GenesisL1 explorer

MolNFT v1 · #164808 · protein

Human nampt in complex with nicotinic acid and phosphoribosyl pyrophosphate

6TA0 · Nicotinamide phosphoribosyltransferase: “Human nampt in complex with nicotinic acid and phosphoribosyl pyrophosphate”. X-ray diffraction, 2 ligands (PRP, NIO), 6 pockets (best druggability 0.80). MolNFT v1 #164808 on GenesisL1: 3D…

PDB
6TA0
Type
protein
Length
935 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
PRP, NIO
Pockets
6 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46741% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46841% helix, 19% strandP43490

Ligands and binding sites

  • PRP · 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose · ligand · 2 copies · chains A, B
  • NIO · Nicotinic acid · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18130.800.8379PRP, NIO
27470.790.8377PRP, NIO
37930.750.8059empty
41080.380.7524empty
5560.340.7819empty

Interfaces

1 interface between chains.

  • A–B · 4280 Ų buried · 78 hydrogen bonds · protein-protein

Compared structures

  • 6TA0 · Human NAMPT in complex with nicotinic acid and phosphoribosyl pyrophosphate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.